Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F98XK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,043
Award facts
- Contract value 100% obligated
- $21,043.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,043.11 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units). The contract is a firm fixed-price, non-set-aside award with a completion date of January 15, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with operations coordinated through its Corporate Office division. The parent entity, Cencora, Inc. (operating as AmerisourceBergen), holds the master IDC valued at $999,999,999.00 through December 2031, which supports the delivery of a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally.
Ondansetron is an antiemetic medication commonly used in military and veteran healthcare settings to manage nausea and vomiting. This delivery order is consistent with AmerisourceBergen's established role as a critical vendor within the federal medical supply chain, particularly for the Defense Logistics Agency's pharmaceutical support operations. The award underscores the company's continued capability to meet federal procurement requirements through open competition and demonstrates the operational efficiency of the DLA's Indefinite Delivery Contract vehicle for fulfilling routine pharmaceutical resupply needs across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F98XK?
SPE2DR26F98XK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F98XK worth?
The government has obligated $21,043 on SPE2DR26F98XK.
Is contract SPE2DR26F98XK an order under another contract?
Yes. SPE2DR26F98XK is a delivery order under SPE2DR25D7060, an indefinite delivery contract.
Was contract SPE2DR26F98XK competed?
The extent of competition for SPE2DR26F98XK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award